Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Protara Therapeutics, Inc. (TARA) had Return on Tangible Equity of -26.68% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-44.60M |
|
-- |
|
-- |
|
$49.15M |
|
$-49.15M |
|
$4.56M |
|
$-44.60M |
|
$-44.60M |
|
$-44.60M |
|
$-44.60M |
|
$-44.60M |
|
$-44.60M |
|
$-49.15M |
|
$-49.51M |
|
20.59M |
|
20.59M |
|
$-2.17 |
|
$-2.17 |
|
| Balance Sheet Financials | |
$172.16M |
|
$1.03M |
|
$9.30M |
|
$181.45M |
|
$10.96M |
|
-- |
|
$3.36M |
|
$14.32M |
|
$167.13M |
|
$167.13M |
|
$167.13M |
|
35.05M |
|
| Cash Flow Statement Financials | |
$-35.81M |
|
$19.16M |
|
$139.87M |
|
$40.33M |
|
$163.54M |
|
$123.21M |
|
$4.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.71 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-35.87M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-26.68% |
|
|
Return on Tangible Equity |
-26.68% |
-24.58% |
|
-26.68% |
|
$4.77 |
|
$-1.74 |
|
$-1.74 |
|